Dr. Zimmerman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
180 Harvester Dr Ste 110
Burr Ridge, IL 60527Phone+1 773-834-4064- Is this information wrong?
Education & Training
- University of ChicagoFellowship, Hematology and Medical Oncology, 1992 - 1995
- McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 1987 - 1992
- University of Illinois College of MedicineClass of 1989
Certifications & Licensure
- IL State Medical License 1991 - 2020
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- Flavopiridol in Treating Patients With Recurrent Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma or Mantle Cell Lymphoma Start of enrollment: 1997 Sep 01
- Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Metastatic Kidney Cancer Start of enrollment: 1999 Feb 01
- Chemotherapy Plus Biological Therapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer Start of enrollment: 1998 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 14 citationsIndatuximab ravtansine plus dexamethasone with lenalidomide or pomalidomide in relapsed or refractory multiple myeloma: a multicentre, phase 1/2a studyKevin R. Kelly, Sikander Ailawadhi, David S. Siegel, Leonard T. Heffner, George Somlo, Sundar Jagannath, Todd M. Zimmerman, Nikhil C. Munshi, Sumit Madan, Asher Chanan...> ;The Lancet. Haematology. 2021 Nov 1
- 69 citationsBortezomib, lenalidomide, and dexamethasone with or without elotuzumab in patients with untreated, high-risk multiple myeloma (SWOG-1211): primary analysis of a random..., , , , , , , , , , , , , , , , > ;The Lancet. Haematology. 2021 Jan 1
- 49 citationsCarfilzomib, lenalidomide, and dexamethasone plus transplant in newly diagnosed multiple myeloma., , , , , , , , , , , , , , , , , , , > ;Blood. 2020 Nov 26
- Join now to see all
Hospital Affiliations
- OSF Healthcare Little Company of Mary Medical CenterEvergreen Park, Illinois
- University of Chicago Medical CenterChicago, Illinois
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: